| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 399,1 k € | — | — | — | |||||||||||||||||||
| Gross margin | 249,8 k € | -7.6% | 270,3 k € | +52.7% | 177,0 k € | -7.9% | 192,3 k € | -12.7% | 220,2 k € | -50.5% | 444,9 k € | +78.9% | 248,7 k € | +15.6% | 215,1 k € | -8.4% | 234,9 k € | -22.1% | 301,4 k € | -13.9% | 350,0 k € | +15.9% | 301,9 k € | +20.9% | 249,7 k € | -7.9% | 271,0 k € | +3.0% | 262,9 k € | +46.3% | 179,7 k € | +9.4% | 164,3 k € | +9.9% | 149,5 k € | +7.1% | 139,6 k € | |
| EBITDA | 238,1 k € | -7.9% | 258,6 k € | +55.6% | 166,2 k € | -8.6% | 181,7 k € | -13.4% | 209,9 k € | -51.9% | 436,0 k € | +81.2% | 240,6 k € | +18.0% | 204,0 k € | +113.5% | 95,5 k € | -67.2% | 291,2 k € | -14.0% | 338,8 k € | +14.2% | 296,7 k € | +20.9% | 245,4 k € | -7.4% | 265,1 k € | +2.3% | 259,2 k € | +47.0% | 176,4 k € | +8.8% | 162,2 k € | +10.1% | 147,3 k € | +6.5% | 138,3 k € | |
| Operating profit | 158,5 k € | -14.4% | 185,2 k € | +60.4% | 115,5 k € | -6.2% | 123,0 k € | -22.2% | 158,1 k € | -55.0% | 351,4 k € | +83.1% | 191,9 k € | +38.6% | 138,5 k € | +260.4% | 38,4 k € | -85.3% | 260,8 k € | +7.2% | 243,2 k € | +0.0% | 243,1 k € | +31.5% | 184,9 k € | +7.4% | 172,1 k € | +76.6% | 97,4 k € | +25.9% | 77,4 k € | -23.9% | 101,6 k € | +43.7% | 70,7 k € | +45.4% | 48,6 k € | |
| Profit/loss | 104,1 k € | -13.9% | 121,0 k € | +68.0% | 72,0 k € | +10.8% | 65,0 k € | -23.5% | 84,9 k € | -65.8% | 248,5 k € | +65.1% | 150,5 k € | +91.6% | 78,6 k € | +233.1% | -59,0 k € | -129.9% | 197,1 k € | +21.8% | 161,8 k € | +0.4% | 161,2 k € | +10.8% | 145,5 k € | +10.0% | 132,2 k € | +99.6% | 66,2 k € | +41.6% | 46,8 k € | -39.4% | 77,2 k € | +100.5% | 38,5 k € | +20.3% | 32,0 k € | |
| Equity | 1,5 M € | +7.4% | 1,4 M € | +3.2% | 1,4 M € | +5.5% | 1,3 M € | +5.2% | 1,2 M € | +7.4% | 1,1 M € | -0.0% | 1,1 M € | +15.2% | 990,0 k € | +8.6% | 911,4 k € | -6.1% | 970,5 k € | +25.5% | 773,3 k € | +29.9% | 595,3 k € | +37.1% | 434,2 k € | +50.4% | 288,7 k € | +84.5% | 156,5 k € | +73.3% | 90,3 k € | -69.2% | 293,5 k € | +21.6% | 241,4 k € | -17.1% | 291,1 k € | |
| Total assets | 1,9 M € | -3.6% | 2,0 M € | +4.5% | 1,9 M € | +1.4% | 1,9 M € | +2.7% | 1,8 M € | +5.0% | 1,7 M € | +15.7% | 1,5 M € | +2.3% | 1,5 M € | +5.8% | 1,4 M € | -8.8% | 1,5 M € | -9.2% | 1,7 M € | +28.1% | 1,3 M € | +6.5% | 1,2 M € | -0.3% | 1,2 M € | +11.5% | 1,1 M € | +62.9% | 679,9 k € | +49.0% | 456,2 k € | +1.8% | 448,2 k € | -11.4% | 505,6 k € | |
| Cash | 76,5 k € | -6.2% | 81,6 k € | +2209.8% | 3,5 k € | +6.1% | 3,3 k € | -9.2% | 3,7 k € | -56.4% | 8,4 k € | -62.2% | 22,2 k € | +579.0% | 3,3 k € | +360.5% | 711,5 € | -98.5% | 46,0 k € | -28.6% | 64,4 k € | -41.0% | 109,2 k € | +699.8% | 13,6 k € | +42.4% | 9,6 k € | -13.7% | 11,1 k € | +39.3% | 8,0 k € | -84.6% | 51,9 k € | +378.3% | 10,8 k € | -60.7% | 27,6 k € | |
| Debts | 403,0 k € | -31.1% | 585,2 k € | +7.6% | 544,1 k € | -7.6% | 589,0 k € | -2.4% | 603,7 k € | +0.6% | 600,0 k € | +65.2% | 363,3 k € | -24.4% | 480,6 k € | +0.5% | 478,1 k € | -10.4% | 533,8 k € | -39.7% | 885,4 k € | +27.3% | 695,5 k € | -10.4% | 776,5 k € | -17.9% | 946,1 k € | -0.5% | 951,2 k € | +61.3% | 589,6 k € | +271.9% | 158,5 k € | -23.3% | 206,6 k € | -3.7% | 214,5 k € | |
Private limited company · Oostende · incorporated on 16/02/2001
Private limited company profitable and well capitalised. Cash position declining (-6.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. VANWULPEN is a Private limited company incorporated in 2001. Its main activity is: Specialist medical practice activities. Its registered office is in Oostende.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette